Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment
Phase 2
- Conditions
- Alveolitis Extrinsic AllergicPulmonary Fibrosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2015-07-14
- Lead Sponsor
- Grupo Medifarma, S. A. de C. V.
- Target Recruit Count
- 60
- Registration Number
- NCT02496182
- Locations
- 🇲🇽
Instituto Nacional de Enfermedades Respiratorias, Mexico city, Distrito Federal, Mexico
© Copyright 2025. All Rights Reserved by MedPath